or Try an Advanced Search...

    Treatment Of Breast Cancer Stocks List

    Symbol Grade Name % Change
    HOLX A Hologic, Inc. 1.81
    GTHX A G1 Therapeutics, Inc. 0.00
    ACHV B Achieve Life Sciences, Inc. 0.64
    ICAD B icad inc. -2.15
    PBYI C Puma Biotechnology Inc 3.51
    NKTR C Nektar Therapeutics 3.36
    VSTM C Verastem, Inc. 4.26
    SLS C SELLAS Life Sciences Group, Inc. 0.85
    ZNTL D Zentalis Pharmaceuticals, Inc. 21.61
    SLRX F Salarius Pharmaceuticals, Inc. -8.07
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies Software - Application
    Related Stock Lists: Breast Cancer Cancer Biopharmaceutical Medicine Ovarian Cancer Drugs Her2 Her2/Neu Oncology Advanced Cancer Antiestrogens Biotechnology Breast Imaging Cancer Screening Clinical Development Clinical Medicine Endometrial Cancer Epidermal Growth Factor Receptor Estrogen Estrogen Receptor

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Breast Cancer stocks.

    Symbol Grade Name Weight
    CNCR F Loncar Cancer Immunotherapy ETF 1.22
    BBC B Virtus LifeSci Biotech Clinical Trials ETF 0.26
    SBIO B ALPS Medical Breakthroughs ETF 0.15
    FSCC D Trust Federated Hermes MDT Small Cap Core ETF 0.05
    FESM B Fidelity Enhanced Small Cap ETF 0.04
    View all Treatment Of Breast Cancer ETFs...
    Compare ETFs
    Compare BBC to FESM Compare BBC to FSCC Compare CNCR to FESM

        Treatment Of Breast Cancer Stocks Recent News

        Date Stock Title
        Nov 1 VSTM Verastem Oncology submits NDA for ovarian cancer treatment
        Nov 1 VSTM Verastem Oncology completes rolling NDA submission to FDA for ovarian cancer treatment
        Oct 31 NKTR Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets
        Oct 31 VSTM Verastem Oncology Completes Rolling NDA Submission to the FDA for Avutometinib Plus Defactinib as a Treatment for Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
        Oct 31 VSTM Verastem Oncology to Participate in Upcoming Investor Conferences
        Oct 30 HOLX Steris (STE) Reports Next Week: Wall Street Expects Earnings Growth
        Oct 30 HOLX Unlocking Q4 Potential of Hologic (HOLX): Exploring Wall Street Estimates for Key Metrics
        Oct 29 NKTR Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases
        Oct 28 HOLX Hologic: Continued Room Amidst Bolt-On M&A Efforts
        Oct 28 HOLX Hologic (HOLX) Stock Falls Amid Market Uptick: What Investors Need to Know
        Oct 28 PBYI 3 US Penny Stocks With Market Caps Under $700M
        Oct 28 HOLX Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
        Oct 28 HOLX FDA advises clinicians to stop using Hologic radiographic markers
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies Software - Application
        Related Stock Lists: Antiestrogens Biopharmaceutical Breast Cancer Cancer Drugs Epidermal Growth Factor Receptor Estrogen Estrogen Receptor Her2 Her2/Neu Hormones Metastatic Breast Cancer Molecule Therapeutics Receptor Positive Selective Estrogen Receptor Degraders Transcription Factors Tyrosine Kinase Receptors
        Treatment Of Breast Cancer

        Treatment of breast cancer depends on the type and stage of the cancer, as well as the patient's age, overall health, and personal preferences. Treatment options may include surgery, radiation therapy, chemotherapy, hormone therapy, targeted therapy, and/or immunotherapy.

        Browse All Tags